Atossa Therapeutics, Inc.
Updated

Long | ATOS

317
ATOS

* All the data is in chart,

TP1 ~ 2.55
TP2 ~2.75
Note
Before July 100% Profit
Note
I smell buy out or merge, consolidating at this level , and 50m $ Direct offering exactly before P2 FDA results.
a huge uptrend possibility here

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.